The metastatic niche and stromal progression
暂无分享,去创建一个
[1] D. Lyden,et al. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. , 2011, Seminars in cancer biology.
[2] Edi Brogi,et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.
[3] E. Fuchs,et al. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling , 2011, Proceedings of the National Academy of Sciences.
[4] J. Abastado,et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. , 2010, The Journal of clinical investigation.
[5] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[6] J. Kappes,et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. , 2007, Blood.
[7] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[8] Z. Werb,et al. The fibroblastic coconspirator in cancer progression. , 2005, Cold Spring Harbor symposia on quantitative biology.
[9] S. Segal,et al. CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells1 , 2005, The Journal of Immunology.
[10] 中村 力也. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer , 2008 .
[11] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[12] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[13] C. Brennan,et al. Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia , 2012, PloS one.
[14] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[15] D. Aust,et al. Lymphangiogenesis in Regional Lymph Nodes Is an Independent Prognostic Marker in Rectal Cancer Patients after Neoadjuvant Treatment , 2011, PloS one.
[16] R. Aft,et al. Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial–Mesenchymal Transition Predicts for Human Breast Cancer Recurrence , 2011, Molecular Cancer Research.
[17] Thomas Kirchner,et al. Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.
[18] H. Huber,et al. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. , 2007, Oncogene.
[19] Hiroyuki Aburatani,et al. The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.
[20] Jason L. Townson,et al. Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases , 2003, Breast Cancer Research and Treatment.
[21] J. Sleeman,et al. New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment , 2007, Clinical & Experimental Metastasis.
[22] M. Kitagawa,et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. , 2008, Cancer research.
[23] J. Massagué,et al. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. , 2011, Cancer cell.
[24] R. M. Simpson,et al. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. , 2010, Cancer research.
[25] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[26] G. Berx,et al. Concepts of metastasis in flux: the stromal progression model. , 2012, Seminars in cancer biology.
[27] C. Brinckerhoff,et al. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. , 1991, The Journal of clinical investigation.
[28] D. Jeoung,et al. Metastasis Suppressor KAI1/CD82 Attenuates the Matrix Adhesion of Human Prostate Cancer Cells by Suppressing Fibronectin Expression and β 1 Integrin Activation , 2011, Cellular Physiology and Biochemistry.
[29] Raghu Kalluri,et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization , 2011, Proceedings of the National Academy of Sciences.
[30] R. Weinberg,et al. Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.
[31] S. Rafii,et al. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.
[32] J. Califano,et al. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function , 2006, The Journal of experimental medicine.
[33] B. Fingleton,et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.
[34] G. Semenza,et al. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis , 2012, Journal of Molecular Medicine.
[35] J. Massagué,et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. , 2011, Cancer cell.
[36] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[37] H. Moses,et al. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. , 2010, Cancer research.
[38] Simone Brabletz,et al. The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer? , 2010, EMBO reports.
[39] A. Robeva,et al. Serum Amyloid A (apoSAA) Expression Is Up-Regulated in Rheumatoid Arthritis and Induces Transcription of Matrix Metalloproteinases , 2001, The Journal of Immunology.
[40] M. Nieto,et al. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.
[41] C. Brennan,et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.
[42] P. Szlosarek,et al. Tumour necrosis factor-alpha as a tumour promoter. , 2006, European journal of cancer.
[43] Jochen Herms,et al. Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.
[44] M. Zöller,et al. CD44v6 dependence of premetastatic niche preparation by exosomes. , 2009, Neoplasia.
[45] S. Jonjić,et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.
[46] D. Radisky,et al. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development , 2008, Clinical & Experimental Metastasis.
[47] S. Rafii,et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. , 2012, Cancer research.
[48] K. Pienta,et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. , 2011, The Journal of clinical investigation.
[49] M. Shibuya,et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.
[50] Daniel Benten,et al. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells , 2011, Hepatology.
[51] J. Aguirre-Ghiso,et al. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. , 2001, Molecular biology of the cell.
[52] W. Kim,et al. High FOXP3+ regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer , 2011, British Journal of Cancer.
[53] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[54] I. Fabregat,et al. Snail blocks the cell cycle and confers resistance to cell death. , 2004, Genes & development.
[55] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.
[56] Germaine Greer,et al. van Deventer H , 1968 .
[57] M. Prados,et al. Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept , 2011, Clinical Cancer Research.
[58] K. Csiszȧr,et al. A molecular role for lysyl oxidase‐like 2 enzyme in Snail regulation and tumor progression , 2005, The EMBO journal.
[59] Michael F Clarke,et al. The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.
[60] A. Mansfield,et al. Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer , 2009, BMC Cancer.
[61] K. Pienta,et al. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. , 2010, Neoplasia.
[62] Daorong Wang,et al. Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas , 2011, BMC Cancer.
[63] J. Sleeman,et al. Angiogenesis , Metastasis , and the Cellular Microenvironment Role of Fibulin-5 in Metastatic Organ Colonization , 2011 .
[64] M. Panaro,et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. , 2009, Cancer research.
[65] R. Badolato,et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.
[66] Christopher S. Chen,et al. Matrix rigidity regulates a switch between TGF-β1–induced apoptosis and epithelial–mesenchymal transition , 2012, Molecular biology of the cell.
[67] H. Yu,et al. Overexpression of VEGF and Angiopoietin 2: A Key to High Vascularity of Hepatocellular Carcinoma? , 2003, Modern Pathology.
[68] A. Ruddell,et al. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. , 2007, The American journal of pathology.
[69] C. Horak,et al. The role of metastasis suppressor genes in metastatic dormancy , 2008 .
[70] R. Wersto,et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells. , 2011, Cancer research.
[71] S. Briest,et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. , 2009, Cancer research.
[72] A. Chambers,et al. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. , 2010, European journal of cancer.
[73] K. Arihiro,et al. FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients. , 2009, Oncology reports.
[74] J. Leips,et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. , 2007, Cancer research.
[75] Lei Zhao,et al. Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. , 2012, Blood.
[76] G. Browne,et al. ZEB proteins link cell motility with cell cycle control and cell survival in cancer , 2010, Cell cycle.
[77] B. Kandemir,et al. Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx , 2010, Diagnostic pathology.
[78] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[79] P. Szlosarek,et al. Tumour necrosis factor-α as a tumour promoter , 2006 .
[80] G. Ahn,et al. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. , 2008, Cancer cell.
[81] J. Sleeman,et al. Building the niche: the role of the S100 proteins in metastatic growth. , 2012, Seminars in cancer biology.
[82] M. Clarke,et al. Cancer stem cells: models and concepts. , 2007, Annual review of medicine.
[83] K. Alitalo,et al. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. , 2007, Blood.
[84] L. Coussens,et al. Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonization , 2011, International journal of cancer.
[85] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[86] Y. Maru,et al. Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis , 2011, Oncogene.
[87] J. Settleman,et al. Oncogenic K-ras “addiction” and synthetic lethality , 2009, Cell cycle.
[88] C. Chiang,et al. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma. , 2012, Oral oncology.
[89] I. Macdonald,et al. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. , 2000, Cancer research.
[90] J. Erler,et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.
[91] D. Schlaepfer,et al. Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.
[92] S. Vandenberg,et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.
[93] S. Hellman,et al. Aging, progression, and phenotype in breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[94] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[95] J. Aguirre-Ghiso,et al. Dormancy of metastatic melanoma , 2010, Pigment cell & melanoma research.
[96] D. Longo,et al. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. , 1995, Journal of immunology.
[97] Peter Carmeliet,et al. Hypoxia and inflammation. , 2011, The New England journal of medicine.
[98] M. Jo,et al. Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling* , 2009, The Journal of Biological Chemistry.
[99] M. Fishbein,et al. The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[100] Hiroyuki Aburatani,et al. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.
[101] Xin Lu,et al. Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis , 2010, Clinical Cancer Research.
[102] J. Sleeman,et al. Do all roads lead to Rome? Routes to metastasis development , 2011, International journal of cancer.
[103] W. Ellis,et al. Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence , 2009, Clinical Cancer Research.
[104] Hong Peng,et al. Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.
[105] S. Bicciato,et al. The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.
[106] Tatyana Chernova,et al. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. , 2007, Molecular biology of the cell.
[107] Satoshi Hirakawa,et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis , 2005, The Journal of experimental medicine.
[108] Hubing Shi,et al. Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. , 2009, Cancer research.
[109] G. Camussi,et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. , 2011, Cancer research.
[110] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[111] H. Huber,et al. PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progression , 2007, Oncogene.
[112] M. Schwaiger,et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. , 2008, Cancer cell.
[113] Bethan Psaila,et al. The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.
[114] M. Karin,et al. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.
[115] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[116] Q. Lin,et al. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics , 2010, Cancer biology & therapy.
[117] Ricardo Garcia,et al. Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis , 2011, Cell.
[118] Yong Liu,et al. Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression , 2010, Proceedings of the National Academy of Sciences.
[119] L. Vermeulen,et al. Cancer stem cell niche: the place to be. , 2011, Cancer research.
[120] Alfredo Quiñones-Hinojosa,et al. Oxygen in stem cell biology: a critical component of the stem cell niche. , 2010, Cell stem cell.
[121] Nicola Elvassore,et al. Role of YAP/TAZ in mechanotransduction , 2011, Nature.
[122] T. Nishiyama,et al. Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture* , 2009, The Journal of Biological Chemistry.
[123] L. Norton,et al. Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[124] P. Carmeliet,et al. A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours , 2011, Nature.
[125] J. Serody,et al. Tumorigenesis and Neoplastic Progression C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9 , 2010 .
[126] R. Maestro,et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.
[127] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[128] G. Semenza,et al. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation , 2011, Proceedings of the National Academy of Sciences.